HLA-A and COVID-19: Firstly, the YLQ peptide is highly immunogenic in most COVID-19 recovered HLA-A*02:01+ individuals and weakly or not recognised in healthy individuals [18], so in the absence of antibodies, this could be used as a marker of infection.